{"id":4868,"date":"2025-03-25T12:57:29","date_gmt":"2025-03-25T12:57:29","guid":{"rendered":"https:\/\/www.nordicbioscience.com\/?post_type=biomarker-solution&p=4868"},"modified":"2025-06-01T09:02:50","modified_gmt":"2025-06-01T09:02:50","slug":"hepatic-diseases","status":"publish","type":"biomarker-solution","link":"https:\/\/www.nordicbioscience.com\/biomarker-solution\/hepatic-diseases\/","title":{"rendered":"Hepatic Diseases"},"content":{"rendered":"
\n
\n
\n

Biomarkers for Hepatic Diseases<\/h1>\n

Nordic Bioscience\u2019s hepatic biomarkers can be of great value in hepatic diseases and liver conditions with fibrotic involvement such as MASH, MASLD, Viral Liver Disease, Immune-Mediated Liver Disease (AIH, PBC and PSC), Alcohol-related Liver Disease (ALD) and similar conditions, including biomarkers for liver cancer. <\/p>\n

\n \n Browse hepatology biomarkers \n \n <\/svg>\n \n <\/a>\n <\/div>\n <\/article>\n <\/div>\n<\/section>\n\n\n\n\n
\n \n
\n
\n
\n
\n

Biomarkers for alcohol-related liver disease (ALD) <\/h2>\n \n\n <\/div>\n
\n

Diagnosis and prediction of disease progression in Alcohol-related Liver Disease (ALD), especially in cirrhosis, has proven difficult. Our diagnostic and prognostic biomarkers have the potential to greatly benefit patients by helping in the early diagnosis of the disease and initiating the most appropriate treatment at the right time.<\/p>\n <\/div>\n

\n

Publications<\/h3>\n